Please Bring Your ~Rotocol, but Do Not Bring Slides Or Microscopes to T He Meeting, CALIFORNIA TUMOR TISSUE REGISTRY
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Differential Diagnosis of Ovarian Mucinous Tumours Sigurd F
Differential Diagnosis of Ovarian Mucinous Tumours Sigurd F. Lax LKH Graz II Academic Teaching Hospital of the Medical University Graz Pathology Mucinous tumours of the ovary • Primary ➢Seromucinous tumours ➢Mucinous tumours ➢Benign, borderline, malignant • Secondary (metastatic) ➢Metastases (from gastrointestinal tract) • Metastases can mimic primary ovarian tumour Mucinous tumours: General • 2nd largest group after serous tumours • Gastro-intestinal differentiation (goblet cells) • Endocervical type> seromucinous tumours • Majority is unilateral, particularly cystadenomas and borderline tumours • Bilaterality: rule out metastatic origin • Adenoma>carcinoma sequence reflected by a mixture of benign, atypical proliferating and malignant areas within the same tumour Sero-mucinous ovarian tumours • Previous endocervical type of mucinous tumor • Mixture of at least 2 cell types: mostly serous • Association with endometriosis; multifocality • Similarity with endometrioid and serous tumours, also immunophenotype • CK7, ER, WT1 positive; CK20, cdx2 negativ • Most cystadenoma and borderline tumours • Carcinomas rare and difficult to diagnose Shappel et al., 2002; Dube et al., 2005; Vang et al. 2006 Seromucinous Borderline Tumour ER WT1 Seromucinous carcinoma being discontinued? • Poor reproducibility: Low to modest agreement from 39% to 56% for 4 observers • Immunophenotype not unique, overlapped predominantly with endometrioid and to a lesser extent with mucinous and low-grade serous carcinoma • Molecular features overlap mostly with endometrioid -
A Case of Krukenberg Tumor Metastasized from Colon Cancer In
A case of Krukenberg tumor metastasized from colon cancer in pregnancy Oztas E, Ozler S, Ersoy AO, Turker M, Zengın NI, Caglar AT, Danisman N Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey Objective Krukenberg tumor refers to gastrointestinal cancer metastatic to the ovaries and has an extremely poor prognosis, with a 5-year survival rate ranging from 12% to 23. 4%. Gastric cancer has been reported as the most frequent primary source of Krukenberg tumor; however, tumors of the colon, appendix, breast, lung, and pancreas have also been reported to metastasize into the ovaries. Krukenberg tumors are usually seen in the fifth decade of life, with an average age of 45 years and cases diagnosed during pregnancy are thus extremely rare. Methods We report a case of a Krukenberg tumor secondary to colon carcinoma in a pregnant woman with acute pelvic pain. The prenatal diagnosis was made at 17 weeks’ gestation. Results A 27-year-old, primigravida with a semisolid right adnexial mass was presented with acute pelvic pain at 17 weeks’ gestation. Ultrasonography revealed a semisolid right adnexial mass of 140×130 mm and ascites, as well as a single live fetus compatible for gestational age. The abdomen was tense, tender and distended so exploratory laparotomy was performed with the suspicion of ovarian torsion. During the operation, ascites, enlarged right ovary with the presence of a necrotic tumor measuring 160×140 mm causing ovarian torsion and omental metastasis were seen. Unilateral oophorectomy and omentectomy were then performed. Histopathological examination of the specimen revealed adenocarcinoma metastasis to the ovary and the omentum probably originating from a primary gastrointestinal carcinoma (Figure-1). -
Life Expectancy and Incidence of Malignant Disease Iv
LIFE EXPECTANCY AND INCIDENCE OF MALIGNANT DISEASE IV. CARCINOMAOF THE GENITO-URINARYTRACT CLAUDE E. WELCH,' M.D., AND IRA T. NATHANSON,? MS., M.D. (Front the Collis P. Huntington Memorial Hospital of Harvard University, and the Pondville State Hospitul, Wre~ztham,Mass.) In previous communications the life expectancy of patients with cancer of the breast (I), oral cavity (2), and gastro-intestinal tract (3) has been discussed. In the present paper the life expectancy of patients with carci- noma of the genito-urinary tract will be considered. The discussion will include cancer of the vulva, vagina, cervix and fundus uteri, ovary, penis, testicle, prostate, bladder, and kidney. All cases of cancer of these organs admitted to the Collis P. Huntington Memorial and Pondville Hospitals in the years 1912-1933 have been reviewed personally. It must again be stressed that these hospitals are organized strictly for the care of cancer patients. All those with cancer that apply are admitted for treatment; many of them have only terminal care. Only those cases in which a definite history of the date of onset could not be determined or in which the diagnosis was uncertain have been omitted in the present study. In compiling statistics on age and sex incidence all cases entering the hospitals before Jan. 1, 1936, have been included. The method of calculation of the life expectancy curves was fully described in the first paper (1). No at- tempt to evaluate the number of five-year survivals has been made, since many of the patients did not receive their initial treatment in these hospitals. -
Human Anatomy As Related to Tumor Formation Book Four
SEER Program Self Instructional Manual for Cancer Registrars Human Anatomy as Related to Tumor Formation Book Four Second Edition U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutesof Health SEER PROGRAM SELF-INSTRUCTIONAL MANUAL FOR CANCER REGISTRARS Book 4 - Human Anatomy as Related to Tumor Formation Second Edition Prepared by: SEER Program Cancer Statistics Branch National Cancer Institute Editor in Chief: Evelyn M. Shambaugh, M.A., CTR Cancer Statistics Branch National Cancer Institute Assisted by Self-Instructional Manual Committee: Dr. Robert F. Ryan, Emeritus Professor of Surgery Tulane University School of Medicine New Orleans, Louisiana Mildred A. Weiss Los Angeles, California Mary A. Kruse Bethesda, Maryland Jean Cicero, ART, CTR Health Data Systems Professional Services Riverdale, Maryland Pat Kenny Medical Illustrator for Division of Research Services National Institutes of Health CONTENTS BOOK 4: HUMAN ANATOMY AS RELATED TO TUMOR FORMATION Page Section A--Objectives and Content of Book 4 ............................... 1 Section B--Terms Used to Indicate Body Location and Position .................. 5 Section C--The Integumentary System ..................................... 19 Section D--The Lymphatic System ....................................... 51 Section E--The Cardiovascular System ..................................... 97 Section F--The Respiratory System ....................................... 129 Section G--The Digestive System ......................................... 163 Section -
Ovarian Carcinomas, Including Secondary Tumors: Diagnostically Challenging Areas
Modern Pathology (2005) 18, S99–S111 & 2005 USCAP, Inc All rights reserved 0893-3952/05 $30.00 www.modernpathology.org Ovarian carcinomas, including secondary tumors: diagnostically challenging areas Jaime Prat Department of Pathology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain The differential diagnosis of ovarian carcinomas, including secondary tumors, remains a challenging task. Mucinous carcinomas of the ovary are rare and can be easily confused with metastatic mucinous carcinomas that may present clinically as a primary ovarian tumor. Most of these originate in the gastrointestinal tract and pancreas. International Federation of Gynecology and Obstetrics (FIGO) stage is the single most important prognostic factor, and stage I carcinomas have an excellent prognosis; FIGO stage is largely related to the histologic features of the ovarian tumors. Infiltrative stromal invasion proved to be biologically more aggressive than expansile invasion. Metastatic colon cancer is frequent and often simulates ovarian endometrioid adenocarcinoma. Although immunostains for cytokeratins 7 and 20 can be helpful in the differential diagnosis, they should always be interpreted in the light of all clinical information. Occasionally, endometrioid carcinomas may exhibit a microglandular pattern simulating sex cord-stromal tumors. However, typical endometrioid glands, squamous differentiation, or an adenofibroma component are each present in 75% of these tumors whereas immunostains for calretinin and alpha-inhibin are negative. Endometrioid carcinoma of the ovary is associated in 15–20% of the cases with carcinoma of the endometrium. Most of these tumors have a favorable outcome and they most likely represent independent primary carcinomas arising as a result of a Mu¨ llerian field effect. -
Primary Ovarian Signet Ring Cell Carcinoma: a Rare Case Report
MOLECULAR AND CLINICAL ONCOLOGY 9: 211-214, 2018 Primary ovarian signet ring cell carcinoma: A rare case report JI HYE KIM1, HEE JEONG CHA1,2, KYU-RAE KIM2,3 and KYUNGBIN KIM1 1Department of Pathology, Ulsan University Hospital, Ulsan 44033; 2Division of Pathology, University of Ulsan, College of Medicine, Seoul 05505; 3Department of Pathology, Asan Medical Center, Seoul 05505, Republic of Korea Received April 18, 2018; Accepted June 12, 2018 DOI: 10.3892/mco.2018.1653 Abstract. Signet ring cell carcinoma (SRCC) of the ovary is and may be challenging. We herein report the case a patient most commonly metastatic from a primary lesion. Primary diagnosed with primary SRCC of the ovary. ovarian SRCC is rare, and the distinction between primary and metastatic SRCC of the ovary may be difficult. We Case report herein present a case of primary SRCC of the ovary in a 54-year-old woman presenting with a right ovarian mass A 54-year-old woman was admitted to the Ulsan University sized 20.5x16.5x11.5 cm. Total abdominal hysterectomy with Hospital (Ulsan, South Korea) with a palpable firm abdominal bilateral salpingo-oophorectomy, partial omentectomy and mass. The patient exhibited no major symptoms and had no incidental appendectomy were performed. Upon histological specific past history. The patient underwent an abdominal examination, mucinous carcinoma composed predominantly computed tomography (CT) scan, which revealed a ~20-cm of signet ring cells was observed in the right ovary. The multiseptated cystic and solid mass arising from the right results of immunohistochemical examination included diffuse ovary. The abdominal CT scan did not reveal any lesions in positivity for cytokeratin (CK)7 and CK20, but the tumor was the gastrointestinal tract. -
SJMCR-47474-475.Pdf
DOI: 10.21276/sjmcr.2016.4.7.5 Scholars Journal of Medical Case Reports ISSN 2347-6559 (Online) Sch J Med Case Rep 2016; 4(7):474-475 ISSN 2347-9507 (Print) ©Scholars Academic and Scientific Publishers (SAS Publishers) (An International Publisher for Academic and Scientific Resources) Vulval Papillary Hidradenoma Clinically Mimicking a Sebaceous Cyst- A Case Report Swagata Dowerah, Bandita Das Dept. of Pathology, Assam Medical College, Dibrugarh, Assam *Corresponding author Swagata Dowerah Abstract: Hidradenoma papilliferum is a rare benign adnexal tumor with apocrine differentiation seen in anogenital area of women. We present a 25 year old female presenting with an asymptomatic mass in the vulva. On examination, a single round nodule was seen in the vulva , firm and non-tender. A clinical diagnosis of Bartholin’s cyst was made. On gross examination, a brownish mass measuring 1.5 X 1.5 X 1.5cms was seen which was greyish white on cut section. H &E stained sections showed papillary and complex glandular structures lined by columnar cells with eosinophilic cytoplasm. A diagnosis of papillary hidradenoma was made. This case is presented due to its rarity and to emphasise that while evaluating vulval nodules, hidradenoma needs to be considered, as these lesions lack distinctive clinical characteristics. Keywords: hidradenoma, papilliferum, vulva, sebaceous cyst. INTRODUCTION Hidradenoma papilliferum is a rare benign adnexal tumor having apocrine differentiation ,which usually presents as an asymptomatic flesh-colored nodule in the anogenital area of women [1]. It is considered by some to be an analog of intraductal papilloma of the breast [2]. It probably derives from anogenital mammary-like glands, which often are found in or around the hidradenoma[2, 3]. -
A Rare Cause of Painless Haematuria- Adenocarcinoma of Appendix
Ju ry [ rnal e ul rg d u e S C f h o i l r u a Journal of Surgery r n g r i u e o ] J ISSN: 1584-9341 [Jurnalul de Chirurgie] Case Report Open Access A Rare Cause of Painless Haematuria- Adenocarcinoma of Appendix Shantanu Kumar Sahu1*, Shikhar Agarwal2, Sanjay Agrawal3, Shailendra Raghuvanshi4, Nadia Shirazi5, Saurabh Agrawal1 and Uma Sharma1 1Department of General Surgery, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Uttarakhand, India 2Department of Urology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Uttarakhand, India 3Department of Anesthesia, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Uttarakhand, India 4Department of Radiodiagnosis, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Uttarakhand, India 5Department of Pathology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Uttarakhand, India Abstract Neoplasms of the appendix are rare, accounting for less than 0.5% of all gastrointestinal malignancies and found incidentally in approximately 1% of appendectomy specimen. Carcinoids are the most common appendicular tumors, accounting for approximately 66%, with cystadenocarcinoma accounting for 20% and adenocarcinoma accounting for 10%. Appendiceal adenocarcinomas fall into one of three separate histologic types. The most common mucinous type produces abundant mucin, the less common intestinal or colonic type closely mimics adenocarcinomas found in the colon, and the least common, signet ring cell adenocarcinoma, is quite virulent and associated with a poor prognosis. Adenocarcinoma of appendix is most frequently perforating tumour of gastrointestinal tract due to anatomical peculiarity of appendix which has an extremely thin subserosal and peritoneal coat and the thinnest muscle layer of the whole gastrointestinal tract. -
Pseudomyxoma Peritonei As a Result of Low Grade Appendiceal Mucinous Neoplasm in Association with Ovarian Fibroma
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 13, Issue 1 Ver. X. (Feb. 2014), PP 99-103 www.iosrjournals.org Pseudomyxoma Peritonei As A Result Of Low Grade Appendiceal Mucinous Neoplasm In Association With Ovarian Fibroma. Dr.Deepa.R1 , Dr.R.Sathyalakshmi2 , Dr. Nalli. R . Sumitra Devi3 , Dr. R. Padmavathi4 , Dr.Mary Lilly. S5 Department of Pathology, Stanley Medical College , Chennai , India1. Department of Pathology, Stanley Medical College , Chennai , India2. Department of Pathology, Stanley Medical College , Chennai , India3 Department of Pathology, Stanley Medical College , Chennai , India4. Department of Pathology, Stanley Medical College , Chennai , India5 Abstract: Context : Pseudomyxoma peritonei is a condition caused by the production of abundant mucin by tumor cells which fills the abdominal cavity.(1)The tumor causes fibrosis of tissues and impedes digestion and organ function. If left untreated, tumor and mucin can build up to the point where it compresses vital structures: the colon, the liver, kidneys, stomach, spleen, etc .This disease is most commonly caused by an appendiceal primary tumor. Aims : We describe a case of a 65 year old female with pseudomyxoma peritonei as a result of low grade appendiceal mucinous neoplasm in association with ovarian fibroma . No such cases have been reported in literature till date. Methods and Materials : The patient underwent Left ovariectomy with appendicectomy ,caecal perforation closure and diverting loop ileostomy. Conclusion : Thus we report a rare occurrence of pseudomyxoma peritonei as a result of low grade appendiceal mucinous neoplasm and ovarian fibroma. Key words : Mucinous neoplasm, appendix, ovarian fibroma I. -
SNOMED CT Codes for Gynaecological Neoplasms
SNOMED CT codes for gynaecological neoplasms Authors: Brian Rous1 and Naveena Singh2 1Cambridge University Hospitals NHS Trust and 2Barts Health NHS Trusts Background (summarised from NHS Digital): • SNOMED CT is a structured clinical vocabulary for use in an electronic health record. It forms an integral part of the electronic care record, and serves to represent care information in a clear, consistent, and comprehensive manner. • The move to a single terminology, SNOMED CT, for the direct management of care of an individual, across all care settings in England, is recommended by the National Information Board (NIB), in “Personalised Health and Care 2020: A Framework for Action”. • SNOMED CT is owned, managed and licensed by SNOMED International. NHS Digital is the UK Member's National Release Centre for the creation of, and delegated authority to licence the SNOMED CT Edition and derivatives. • The benefits of using SNOMED CT in electronic care records are that it: • enables sharing of vital information consistently within and across health and care settings • allows comprehensive coverage and greater depth of details and content for all clinical specialities and professionals • includes diagnosis and procedures, symptoms, family history, allergies, assessment tools, observations, devices • supports clinical decision making • facilitates analysis to support clinical audit and research • reduces risk of misinterpretations of the record in different care settings • Implementation plans for England: • SNOMED CT must be implemented across primary care and deployed to GP practices in a phased approach from April 2018. • Secondary care, acute care, mental health, community systems, dentistry and other systems used in direct patient care must use SNOMED CT as the clinical terminology, before 1 April 2020. -
Morphological Patterns of Primary Nonendocrine Human Pancreas Carcinoma'
[CANCER RESEARCH 35, 2234-2248, August 1975] Morphological Patterns of Primary Nonendocrine Human Pancreas Carcinoma' Antonio L Cubifla and Patrick J. Fitzgerald2 Department of Pathology, Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, New York UX@21 Summary the parenchymal cells. In the subsequent 5 decades terms such as mucous adenocarcinoma, colloid carcinoma, duct The study of histological sectionsof 406 casesof nonen adenocarcinoma, pleomorphic cancer, papillary adenocar docrine pancreas carcinoma at Memorial Hospital mdi cinoma, cystadenocarcinoma, and other variants, such as cated that morphological patterns of pancreas carcinoma epidermoid carcinoma, mucoepidermoid cancer, giant-cell could be delineated as follows: duct cell adenocarcinoma carcinoma, adenoacanthoma, and acinar cell carcinoma, (76%), giant-cell carcinoma (5%), microadenocarcinoma have appeared (7, 18, 23, 47, 62). Subtypes of islet-cell (4%), adenosquamous carcinoma (4%), mucinous adeno tumors have been defined (27). As pointed out by Baylor carcinoma (2%), anaplastic carcinoma (2%), cystadenocar and Berg (5) in discussing the limitations of their study of cinoma ( 1%), acinar cell carcinoma (1 %), carcinoma in 5000 patients with pancreas cancer from 8 cancer registries, childhood (under 1%), unclassified (7%). few pathologists precisely characterize the microscopic In 195 cases of patients with pancreas carcinoma, search features of their cases. was made for changes in the pancreas duct epithelium and We have reviewed cases of cancer of the pancreas at these were compared to duct epithelium in a control group Memorial Hospital to determine whether there are defina of 100 pancreases from autopsies of patients with nonpan ble morphological subgroups and to indicate their relative creatic cancer. The following incidences were found for distribution in our material. -
New Jersey State Cancer Registry List of Reportable Diseases and Conditions Effective Date March 10, 2011; Revised March 2019
New Jersey State Cancer Registry List of reportable diseases and conditions Effective date March 10, 2011; Revised March 2019 General Rules for Reportability (a) If a diagnosis includes any of the following words, every New Jersey health care facility, physician, dentist, other health care provider or independent clinical laboratory shall report the case to the Department in accordance with the provisions of N.J.A.C. 8:57A. Cancer; Carcinoma; Adenocarcinoma; Carcinoid tumor; Leukemia; Lymphoma; Malignant; and/or Sarcoma (b) Every New Jersey health care facility, physician, dentist, other health care provider or independent clinical laboratory shall report any case having a diagnosis listed at (g) below and which contains any of the following terms in the final diagnosis to the Department in accordance with the provisions of N.J.A.C. 8:57A. Apparent(ly); Appears; Compatible/Compatible with; Consistent with; Favors; Malignant appearing; Most likely; Presumed; Probable; Suspect(ed); Suspicious (for); and/or Typical (of) (c) Basal cell carcinomas and squamous cell carcinomas of the skin are NOT reportable, except when they are diagnosed in the labia, clitoris, vulva, prepuce, penis or scrotum. (d) Carcinoma in situ of the cervix and/or cervical squamous intraepithelial neoplasia III (CIN III) are NOT reportable. (e) Insofar as soft tissue tumors can arise in almost any body site, the primary site of the soft tissue tumor shall also be examined for any questionable neoplasm. NJSCR REPORTABILITY LIST – 2019 1 (f) If any uncertainty regarding the reporting of a particular case exists, the health care facility, physician, dentist, other health care provider or independent clinical laboratory shall contact the Department for guidance at (609) 633‐0500 or view information on the following website http://www.nj.gov/health/ces/njscr.shtml.